Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian <i>et al</i>' by Notz <i>et al</i>.

Mathian, Alexis; Amoura, Zahir

Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al' by Notz et al.

Mathian, Alexis; Amoura, Zahir.

Mathian A; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France alexis.mathian@aphp.fr.
Amoura Z; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Ann Rheum Dis ; 81(11): e217, 2022 11.

Article in English | MEDLINE | ID: covidwho-947814

Subject(s)

Antirheumatic Agents; COVID-19 Drug Treatment; Lupus Erythematosus, Systemic; Antirheumatic Agents/therapeutic use; Humans; Hydroxychloroquine/therapeutic use; Lupus Erythematosus, Systemic/complications; Lupus Erythematosus, Systemic/drug therapy

Keywords

B-lymphocytes; Covid-19; antirheumatic agents; lupus erythematosus; rituximab; systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antirheumatic Agents / COVID-19 Drug Treatment / Lupus Erythematosus, Systemic Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2020-218795

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google